Browsing 408 Presentations

Sort By

Novel Anti-HER2 Monoclonal Antibody

Presenter
  • Thomas Bachelot (Lyon, France)
Survivorship and quality of life (ID 17) Educational session

PROMISing ways to measure QoL

Lecture Time
18:00 - 18:20
Presenter
  • David Cella (Chicago, United States of America)
Session Name
Survivorship and quality of life (ID 17)
Room
Channel 3
Date
23.05.2020
Time
18:00 - 19:00
Authors
  • David Cella (Chicago, United States of America)

Welcome and Introduction

Presenter
  • Rebecca Dent (Singapore, Singapore)
Management of brain metastases in breast cancer (ID 57) Educational session

Medical treatment of HER2-positive patients

Lecture Time
14:50 - 15:10
Presenter
  • Ana Mafalda Antunes De Melo e Oliveira (Barcelona, Spain)
Session Name
Management of brain metastases in breast cancer (ID 57)
Room
Channel 2
Date
24.05.2020
Time
14:30 - 15:45
Authors
  • Ana Mafalda Antunes De Melo e Oliveira (Barcelona, Spain)
Optimizing the adjuvant treatment of premenopausal patients with HR+/HER2- early breast cancer (ID 61) Young oncologist session

Tailoring follow-up and survivorship care

Lecture Time
19:55 - 20:05
Presenter
  • Ines Vaz Luis (Villejuif, Portugal)
Session Name
Optimizing the adjuvant treatment of premenopausal patients with HR+/HER2- early breast cancer (ID 61)
Room
Channel 2
Date
23.05.2020
Time
19:30 - 20:15
Authors
  • Ines Vaz Luis (Villejuif, Portugal)

Concluding remarks

Presenter
  • Javier Cortés (Barcelona, Spain)
Pathology (ID 14) Educational session

Introduction

Lecture Time
12:45 - 12:45
Presenter
  • Carsten Denkert (Marburg, Germany)
Session Name
Pathology (ID 14)
Room
Channel 3
Date
23.05.2020
Time
12:45 - 14:15
Authors
  • Carsten Denkert (Marburg, Germany)
Adjuvant and neoadjuvant early breast cancer: HER2+ (ID 6) Educational session

Beyond HER2: Dissecting tumour heterogeneity

Lecture Time
14:50 - 15:10
Presenter
  • Aleix Prat (Barcelona, Spain)
Session Name
Adjuvant and neoadjuvant early breast cancer: HER2+ (ID 6)
Room
Channel 1
Date
23.05.2020
Time
14:30 - 16:00
Authors
  • Aleix Prat (Barcelona, Spain)
Translational oncology (ID 15) Educational session

Live Q&A

Lecture Time
17:35 - 17:45
Session Name
Translational oncology (ID 15)
Room
Channel 2
Date
23.05.2020
Time
16:15 - 17:45

New frontiers in the management of HER2+ brain metastases

Presenter
  • Thomas Bachelot (Lyon, France)
Role of loco regional treatment: Now and tomorrow (ID 29) Educational session

Medical oncology treatment

Lecture Time
14:30 - 14:50
Presenter
  • Giuseppe Curigliano (Milan, Italy)
Session Name
Role of loco regional treatment: Now and tomorrow (ID 29)
Room
Channel 3
Date
24.05.2020
Time
14:30 - 15:45
Authors
  • Giuseppe Curigliano (Milan, Italy)

New frontiers in the management of HER2+ brain metastases

Presenter
  • Thomas Bachelot (Lyon, France)